Vans x CoppaFeel! for Breast Cancer Awareness
By Ash CSept. 25 2019, Updated 8:59 p.m. ET
Vans is about to drop some new kicks in collaboration with a U.K-based breast cancer awareness charity CoppaFeel! in honor of Breast Cancer Awareness Month. The limited edition footwear range has a Sk8-Hi sneaker, two low-top slip-ons, an Era silhouette, and also a slide.
An official press release states that the new collection was designed to “educate youth on checking their breasts” and centers on “the beauty and strength of those impacted or touched by breast cancer.” Upon purchase, each shoe will come with diverse breast illustrations that show different appearances and shades of breasts and nipples. The goal is to promote early detection by encouraging young people to better understand and become more in-tune with their bodies.
The Sk8-Hi style features hand-drawn illustrations paired with a black and white design. The checkerboard slip-on comes in a light cream tone with various shades of brown and white, while the black slip-on says “YOU GOT THIS” on top of the shoe. The Era silhouette arrives in a cream color but has a literal blueprint design on the upper. Last but not the least is the slide that is white and features an array of colors on the strap.
In an official statement, Kris Hallenga, founder of CoppaFeel!, discusses their partnership with Vans:
“For our charity, this collaboration with Vans is a dream come true. We are thrilled for the opportunity to spread our message across Vans’ audience, as this partnership will allow us to tell more people why checking their boobs is so important, and in return, save lives. CoppaFeel! exists to stamp out the late detection of breast cancer by educating everyone – girls, boys and non-binary pals about their boobs and encourage them to get anything abnormal checked out.”
The Vans Breast Cancer Awareness collection will be released on October 1, and you can get them from the Vans website. In other news, check out our other story about how onions and garlic can help reduce the risk of breast cancer.